The Endocrine Society now issued a Clinical Practice Guideline (CPG) advising against the usage of testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of diseases involving the testes, pituitary and hypothalamus, it has not been approved for treating age-related declines in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the safety of testosterone. The study included roughly 800 elderly men with low testosterone and symptoms associated with this illness, including http://tinyurl.com/jkhvqy9 sexual and physical dysfunction. The research is expected to shed more light on the security of testosterone treatment since the men's heart health was carefully tracked.
The recent contradictory findings on testosterone therapy prompted his team to conduct a substantial systematic literature search for studies assessing the relationship between testosterone replacement therapy and cardiovascular events among guys and Patel. An estimated 13 million men in America have problems with low testosterone, which happens when the body does not make enough hormones because of a difficulty with the testicles or pituitary gland. This explains the unexpected weight gain, obvious aging and decline of energy of an individual.
And many girls have a knee-jerk suspicion that any hormone treatment can raise their risk of breast cancer. Nevertheless, clinical studies demonstrate that testosterone not only does not raise a woman's risk of breast cancer , it may play a vital role in warding off the disease. Glaser thinks this will likely remain the status quo for a while, given the prohibitive cost of conducting the long-term safety studies needed to gain fuller FDA acceptance.